Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × radium Ra 223 dichloride × Clear all

NCT01798108 2017-05-19

Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases

Phase 1 Completed

Neoplasm Metastasis

NCT00748046 2014-06-25

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Phase 1 Completed

Neoplasm Metastasis, Prostatic Neoplasms